|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/427 | |
| C07D 487/04 | |||
| C07D 403/12 | |||
| C07D 207/09 |
| (11) | Patento numeris | 2770996 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12844551.7 |
| Europos patento paraiškos padavimo data | 2012-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/061252 |
| Data | 2012-10-22 |
| (87) | Numeris | WO 2013/062881 |
| Data | 2013-05-02 |
| (30) | Numeris | Data | Šalis |
| 201161552195 P | 2011-10-27 | US |
| (72) |
YASUDA, Nobuyoshi, US
LIU, Zhuqing, US
ZHONG, Yong-Li, US
CHUNG, John Y., L., US
YASUDA, Nobuyoshi, US
MALONEY, Kevin, M., US
CAMPOS, Kevin, US
HOERRNER, R., Scott, US
LYNCH, Joseph, US
XU, Feng, US
CLEATOR, Edward, GB
GIBSON, Andrew, GB
KEEN, Stephen, GB
LIEBERMANN, Dave, GB
YOSHIKAWA, Naoki, JP
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES |
| PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES |